Unless you live under a rock, youve heard about injectable GLP-1 agonist drugs like semaglutide and tirzepatide (brand names Ozempic and Mounjaro, respectively) that fall under a class of medications called incretin mimetics
The following table highlights some of each drugs most common and serious side effects according to their prescribing labels
The semaglutide plateau troubleshooting guide covers common reasons for stalling, and CagriSema represents a pharmacological solution to that plateau by engaging an entirely new receptor system
On the contrary, a systematic review on mortality, as well as cardiovascular and kidney statuses in patients with T2DM treated with GLP-1RAs concluded that there was no increase in the incidence of severe hypoglycaemia, pancreatitis, or pancreatic cancer (222)
Transcription factors in neurodevelopmental and associated psychiatric disorders: a potential convergence for genetic and environmental risk factors